New research identifies biomarkers in people with radiologically isolated syndrome (RIS) that better predict who will develop ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

MS primarily affects young adults and is more common in women. The prevalence continues to rise globally, including in aging ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A new study is giving hope to people with ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

Increases in sGFAP during BCDT are linked to disability progression in MS, independent of relapse activity. sGFAP is a stronger predictor of disease progression than sNfL, reflecting different ...

An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...